Tag Archive for sales

Zeta Pays $1,4 Million In Commission In The First Month

According to a Zeta press release:
As Allan Badilla stated,
“The 4.0 revolution will make history”, Zeta Group, in its first month has achieved great results and in just 30 days has set multiple records in the industry.
This revolution came to be a benchmark for leadership and economic growth in Latin America and the world, through the leadership of Allan Badilla, Zeta has achieved that its most recognized leaders reach ranks that seemed impossible in such a short time.
The first of these achievements was achieved in just 7 days by Allan Badilla, who reached the double diamond rank, earning a commission of $70,000, demonstrating, once again, that, thanks to his leadership and constant work, it is possible to achieve high-level results in record time.
By reaching this rank, Allan made way for one of its strongest leaders to achieve in just two weeks, being the first Diamond Z, the entrepreneur Miguel Posada, reached this rank in record time.
Following the example of the double diamond, Miguel continues stating that his purpose is to positively impact people and show them that results like this are a reflection of the effort and dedication of a leading organization in a million-dollar industry.
June continued to be a

Read more...

USANA Q2 Preliminary Sales Down 21% To $265 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022.
The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021.
“Our sales performance during the second quarter was below expectations, as COVID-related lockdowns, restrictions, and other disruptions continued in mainland China and other markets,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“These challenges were particularly disruptive to the regional sales program we offered in several key markets during the quarter, and ultimately caused participation in the program, sales results and active customer counts to come in lower than anticipated.
Importantly, this program was designed to be a catalyst for sales and customer growth not only during the quarter, but also in the second half of the year. As a result of this and the continued uncertainty surrounding the operating environment going forward, we anticipate softer sales and customer counts in the second half of the year.”
“We continue to

Read more...

Stemtech Increases Recruitment By 38%

According to a Stemtech press release:
Stemtech Corporation (“Stemtech”) (CQB:OTSTEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company increased independent business partner recruiting by 38% for the period from April 1, 2022 through June 20, 2022, as compared to the same period last year.
Independent business partners include distributors, customers, wholesale buyers, business builders and VIP Customers.
“We are thrilled about the recent increase in recruitment for Stemtech,”
said Charles Arnold, Chairman and CEO of Stemtech.
“Recruitment is the lifeblood of direct sales companies and we are very encouraged by our results so far in the second quarter of 2022. We intend to continue our outreach and expansion efforts, and build on this momentum going forward.”
Stemtech recently moved up 174 places in the Business For Home Momentum Ranks from the previous year, to achieve a ranking of 93 out of a total of 722 of the top companies in the industry. The results can be seen on the Business For Home web site at www.businessforhome.org.

Stemtech specializes in creating products and formulas that are patent protected in the U.S. and international markets. The Company’s patented formulas help the release, circulation and migration of

Read more...

Arieyl $16 Million In Sales With 50,000 Customers

According to an Arieyl press release:
When you look at their product names, the labeling, the opportunity videos, even the picture of the CEO’s on Business for Home – you know for a fact, that Arieyl is NOT your mama’s MLM.
Kristen and Travis Butler burst into the network marketing scene in November of 2020, this time stepping up as CEOs with passion, conviction, and a courageous promise to disrupt and elevate.
In true collaborative fashion, Arieyl’s founders and co-CEOs, Travis and Kristen Butler, teamed up with a small group of family, friends and proven industry leaders equipped with a diverse product line, a lucrative compensation plan and an unique opportunity for those with enough faith to join them on a “Rockstar” adventure.
Arieyl quickly exploded with over 1 million in sales their first week in business.
Opting to produce proprietary formulated supplements over white label stock items sets Arieyl apart from the majority of their competition and has even challenged other world class companies to elevate their existing lines.
Since Arieyl’s conception, only a year and a half ago, the debt free company boosts over 16 million in sales, 50,000 customers and more than 70 stellar health and wellness products.
It’s no wonder that 7,000

Read more...

Medifast – Optavia First Quarter Sales Up 22.6% To $417 Million

Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights Compared to the Prior-Year Period

Revenue increased 22.6% to $417.6 million
21.7% growth in the number of active earning OPTAVIA Coaches to 63,900
Revenue per active earning OPTAVIA Coach increased 1.3% to $6,536
Net income increased 1.7% to $41.8 million
Earnings per diluted share (“EPS”) of $3.59, an increase of 3.8%
Annual revenue guidance raised to $1.78 billion to $1.84 billion and full-year EPS to $14.60 to $16.05

“Record quarterly revenues, sharp acceleration in coach metrics and an increase in our annual financial guidance are powerful indications of the underlying strength of our business.
We have record numbers of independent active earning OPTAVIA Coaches, helping us drive robust product demand and rapidly increasing digital engagement, and bolstering OPTAVIA to the #1 revenue share position among publicly traded companies in the weight management industry in the United States,”
said Dan Chard, Chairman and Chief Executive Officer of Medifast.
“We continue to take advantage of significant opportunities to further leverage our technological innovation and infrastructure. Through deeper integration of key technologies and data analytics, we are enhancing the OPTAVIA customer experience and enabling significant productivity gains for OPTAVIA Coaches.
All of this creates strong potential for further expansion into the broader

Read more...

LR Group 2021 Sales Up 4% To $310 Million

Group sales in 2021 increased by 4.0% to EUR 296.2 million (USA $ 310 Million)
EBITDA reported at the upper end of the earnings forecast at EUR 36.8 million
LR Global Holding GmbH, Europe’s leading digital social selling company in the area of high-quality health and care products, published its final, audited figures for financial year 2021 today, confirming the positive, preliminary figures for the past reporting year.
According to these figures, the LR Group was able to increase its sales (merchandise revenues) by 4.0% to EUR 296.2 million in financial year 2021 (previous year: EUR 284.9 million) and continue its growth course after an extraordinarily strong previous year. All regions contributed positively to the development of sales in 2021.
Furthermore, based on final figures, the LR Group achieved normalised EBITDA of EUR 41.6 million in financial year 2021, compared to EUR 42.5 million in the same period of the previous year.
In addition, the company improved its EBITDA reported slightly to EUR 36.8 million (previous year: EUR 36.7 million). This was at the upper end of the forecast for EBITDA reported of EUR 33 million to EUR 37 million for 2021.
“The LR Group developed successfully and further strengthened its market position in 2021.
This

Read more...

Prüvit Sales Topped $598 Million In 2021

Prüvit, one of the fastest growing health technology brands, was honored at the DSN 2022 Global 100 ceremony in Frisco, Texas for reaching $598 million in yearly revenue.
In addition to the Global 100 list, awards are given out in a variety of categories including leadership, lifetime achievement, meaningful global responsibility, customer centricity, and 2022 best places to work in direct selling, among others. The festivities are complimented by a special-edition print issue, and a networking dinner.
With a top-tier guest list made up of leading executives, the 2022 event was a tremendous success with a virtual broadcast making it possible for people all around the world to join in the experience.
The event is DSN’s celebration of the outstanding achievements of organizations and the executive leaders within the industry who have made big moves and experienced major growth over the past year. They are essentially the Oscars of direct selling with over 1,300 attendees, and more than 35 presenters with a total value of participating companies topping $20 billion.
It was a shining tribute to the unlimited potential of the whole community to grow and evolve into an even brighter future. With the wealth of knowledge of the thought leaders and executive innovators on the

Read more...